Radiopharm Theranostics (ASX:RAD) Land And Improvements: A$0.00 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Radiopharm Theranostics Land And Improvements?

Radiopharm Theranostics ASX:RAD -10.00% Land And Improvements is A$0.00 Mil as of Jun. 2025. The stock has 6 warning signs investors should review.

Radiopharm Theranostics's land and improvements for the quarter that ended in Jun. 2025 was A$0.00 Mil.

Radiopharm Theranostics Land And Improvements Historical Data

* Premium members only.

The historical data trend for Radiopharm Theranostics's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radiopharm Theranostics Land And Improvements Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Land And Improvements
0.00 0.00 0.00 0.00 0.00

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Radiopharm Theranostics Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of A$0.00 Mil mean?
Radiopharm Theranostics (ASX:RAD) has a Land And Improvements of A$0.00 Mil as of Jun. 2025. Land and improvements records the total value of a company's land and improvements to it. View historical data on Radiopharm Theranostics and its competitors.
Is Radiopharm Theranostics' Land And Improvements too high?
Radiopharm Theranostics' current Land And Improvements is A$0.00 Mil.
How does Radiopharm Theranostics' Land And Improvements compare to VRTX and REGN?
Radiopharm Theranostics' Land And Improvements of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Biotechnology company?
A good Land And Improvements depends on the Biotechnology industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Radiopharm Theranostics and its competitors. Radiopharm Theranostics's current Land And Improvements is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiopharm Theranostics stock overvalued right now?
Based on GuruFocus' analysis, Radiopharm Theranostics (ASX:RAD) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 10% below its estimated fair value. The current Land And Improvements is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Radiopharm Theranostics (ASX:RAD), the current Land And Improvements is A$0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radiopharm Theranostics Business Description

Other Exchanges RADX:USA
Address 62 Lygon Street, Suite 1, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.